Verrica Pharmaceuticals Inc. (VRCA) Tops Q1 EPS by 3c

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q1 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $3.44 million versus the consensus estimate of $2.48 million.

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Active options: NVDA TSLA AMZN AAPL MSTR SPCX MU PLTR MSFT WEN SOFI
• Cerebras Systems (CBRS) 16998 contracts of August 115 puts trade, share price down 17.5%